Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Green Chemistry

Cascade Biocatalysts nets $2.6 million in early funding

by Rick Mullin
August 26, 2023 | A version of this story appeared in Volume 101, Issue 28

 

Cascade Biocatalysts, a biomanufacturing firm specializing in green chemistry, raised $2.6 million in a preseed financing round led by Ten VC. Cascade develops processes that make the use of enzymes affordable in a transition from conventional chemistries to more environmentally friendly manufacturing. To date, the Denver-based company has worked on 15 different enzymes for several customers. Cascade hopes to use the funding to scale its operations from lab- to pilot-scale enzyme production.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.